Select for export P.0421 Efficacy and safety of psilocybin in treatment-resistant major depression (EPIsoDE) - study design, rationale and current status No abstract availability was recorded for this entry. Details DOI 10.1016/j.euroneuro.2021.10.394 Copy citation Copy BibTeX European Neuropsychopharmacology 2021-11-30 Lea J. Mertens, Michael Koslowski, Felix Betzler, Ricarda Evens, Maria Gilles, Andrea Jungaberle OpenAlex Published psilocybin DepressionConsciousnessSafety Other More
Select for export P.0885 The effect of psilocybin therapy for depression on low-frequency brain activity in response to music No abstract availability was recorded for this entry. Details DOI 10.1016/j.euroneuro.2021.10.741 Copy citation Copy BibTeX European Neuropsychopharmacology 2021-11-30 Matthew B. Wall, Cynthia Lam, Natalie Ertl, Mendel Kaelen, Leor Roseman, David Nutt OpenAlex Published psilocybin DepressionReceptor Pharmacology Other More
Select for export P.0729 Highlights of psychedelic history and current research on psilocybin application for treatment of depression - a comprehensive literature review No abstract availability was recorded for this entry. Details DOI 10.1016/j.euroneuro.2021.10.797 Copy citation Copy BibTeX European Neuropsychopharmacology 2021-11-30 Sara Penedos, Caio Freitas Ramos, María José López Miguel, Márcio José Martins Alves, Luciana Campos Paulino, Adriano Valério S. Azevêdo OpenAlex Published psilocybin DepressionEating DisordersReview Article Review Article More
Select for export Homebrewed psilocybin: can new routes for pharmaceutical psilocybin production enable recreational use? Abstract available at the source but not redistributed here. Read at source. Details DOI 10.1080/21655979.2021.1987090 PubMed 34607532 Copy citation Copy BibTeX Bioengineered 2021-11-30 Gibbons WJ, McKinney MG, O'Dell PJ, Bollinger BA, Jones JA. Europe PMC Published psilocybin DepressionAnxietyAddiction Other More
Select for export Psilocybin-assisted therapy for the treatment of resistant major depressive disorder (PsiDeR): protocol for a randomised, placebo-controlled feasibility trial. Abstract available at the source but not redistributed here. Read at source. Details DOI 10.1136/bmjopen-2021-056091 PubMed 34853114 Copy citation Copy BibTeX BMJ Open 2021-11-30 Rucker J, Jafari H, Mantingh T, Bird C, Modlin NL, Knight G Europe PMC Published psilocybin DepressionBrain ImagingBiomarkers Randomized Controlled Trial More
Select for export Molecular insights into psychedelic drug action. Abstract available at the source but not redistributed here. Read at source. Details DOI 10.1111/jnc.15540 PubMed 34797943 Copy citation Copy BibTeX Unknown journal 2021-11-30 Slocum ST, DiBerto JF, Roth BL. Europe PMC Published psilocybin DepressionMechanism of ActionReview Article Review Article More
Select for export Marijuana, Hallucinogen Use Reach Historic Levels Among Young Adults Abstract available at the source but not redistributed here. Read at source. Details DOI 10.1176/appi.pn.2021.11.29 Copy citation Copy BibTeX Psychiatric News 2021-11-29 Linda M. Richmond OpenAlex Published psilocybin DepressionAnxietyAddiction Observational Study More
Select for export Psychedelic Drugs for Mental Disorders and Human Potential: Placebo or Panacea Abstract available at the source but not redistributed here. Read at source. Details DOI 10.1176/appi.pn.2021.12.14 Copy citation Copy BibTeX Psychiatric News 2021-11-28 David J. Hellerstein, Kevin A. Sabet, Jeffrey A. Lieberman OpenAlex Published psilocybin DepressionAnxietyConsciousness Clinical Trial More
Select for export Psychedelics for the treatment of depression, anxiety, and existential distress in patients with a terminal illness: a systematic review. Abstract available at the source but not redistributed here. Read at source. Details DOI 10.1007/s00213-021-06027-y PubMed 34812901 Copy citation Copy BibTeX Unknown journal 2021-11-22 Schimmers N, Breeksema JJ, Smith-Apeldoorn SY, Veraart J, van den Brink W, Schoevers RA. Europe PMC Published psilocybin DepressionAnxietyEnd-of-Life Distress Systematic Review More
Select for export Acute Effects of Psilocybin After Escitalopram or Placebo Pretreatment in a Randomized, Double-Blind, Placebo-Controlled, Crossover Study in Healthy Subjects. Abstract available at the source but not redistributed here. Read at source. Details DOI 10.1002/cpt.2487 PubMed 34743319 Copy citation Copy BibTeX Clinical Pharmacology & Therapeutics 2021-11-21 Becker AM, Holze F, Grandinetti T, Klaiber A, Toedtli VE, Kolaczynska KE Europe PMC Published psilocybinpsilocin DepressionAnxietyPharmacology Clinical Trial More
Select for export Adults who microdose psychedelics report health related motivations and lower levels of anxiety and depression compared to non-microdosers. Abstract available at the source but not redistributed here. Read at source. Details DOI 10.1038/s41598-021-01811-4 PubMed 34795334 Copy citation Copy BibTeX Scientific Reports 2021-11-17 Rootman JM, Kryskow P, Harvey K, Stamets P, Santos-Brault E, Kuypers KPC Europe PMC Published psilocybin DepressionAnxietyMicrodosing Observational Study More
Select for export Molecular Mechanisms of Psilocybin and Implications for the Treatment of Depression. Abstract available at the source but not redistributed here. Read at source. Details DOI 10.1007/s40263-021-00877-y PubMed 34791625 Copy citation Copy BibTeX Unknown journal 2021-11-16 Ling S, Ceban F, Lui LMW, Lee Y, Teopiz KM, Rodrigues NB Europe PMC Published psilocybin DepressionPharmacologyMechanism of Action Review Article More
Select for export Human behavioral pharmacology of psychedelics. Abstract available at the source but not redistributed here. Read at source. Details DOI 10.1016/bs.apha.2021.10.003 PubMed 35341564 Copy citation Copy BibTeX Unknown journal 2021-11-10 Strickland JC, Johnson MW. Europe PMC Published psilocybin DepressionAddictionPharmacology Clinical Trial More
Select for export [Rapid-acting antidepressants-neurobiological mechanisms of action]. Abstract available at the source but not redistributed here. Read at source. Details DOI 10.1007/s00115-021-01225-7 PubMed 34766186 Copy citation Copy BibTeX Unknown journal 2021-11-10 Gass P, Vasilescu AN, Inta D. Europe PMC Published psilocybin DepressionNeuroplasticityMechanism of Action Animal Study More
Select for export Daily briefing: Largest trial shows psilocybin is effective to treat depression. No abstract availability was recorded for this entry. Details DOI 10.1038/d41586-021-03413-6 PubMed 34764467 Copy citation Copy BibTeX Nature 2021-11-09 Graham F. Europe PMC Published psilocybin Depression Other More
Select for export From psychiatry to neurology: Psychedelics as prospective therapeutics for neurodegenerative disorders. Abstract available at the source but not redistributed here. Read at source. Details DOI 10.1111/jnc.15509 PubMed 34519052 Copy citation Copy BibTeX Unknown journal 2021-10-21 Kozlowska U, Nichols C, Wiatr K, Figiel M. Europe PMC Published psilocybin DepressionAddictionNeuroplasticity Clinical Trial More
Select for export Finding the divine within: exploring the role of the sacred in psychedelic integration therapy for sexual trauma and dysfunction Abstract available at the source but not redistributed here. Read at source. Details DOI 10.1080/14681994.2021.1994138 Copy citation Copy BibTeX Sexual & Relationship Therapy 2021-10-19 Dee Dee Goldpaugh OpenAlex Published psilocybin DepressionAnxietyPTSD Other More
Select for export The Safety and Efficacy of Psilocybin in Cancer Patients With Major Depressive Disorder Abstract available at the source but not redistributed here. Read at source. Details Copy citation Copy BibTeX ClinicalTrials.gov 2021-10-14 Maryland Oncology Hematology, PA ClinicalTrials.gov CLINICAL TRIAL psilocybin DepressionAnxietyClinical Trial Clinical Trial More
Select for export Novel antidepressant drugs: Beyond monoamine targets. Abstract available at the source but not redistributed here. Read at source. Details DOI 10.1017/s1092852921000791 PubMed 34588093 Copy citation Copy BibTeX Unknown journal 2021-09-29 Gonda X, Dome P, Neill JC, Tarazi FI. Europe PMC Published psilocybin DepressionMechanism of ActionReceptor Pharmacology Clinical Trial More
Select for export Psilocybin: Next to treat depression, OCD and nicotine addiction Abstract available at the source but not redistributed here. Read at source. Details DOI 10.1002/adaw.33204 Copy citation Copy BibTeX Alcoholism & Drug Abuse Weekly 2021-09-23 Alison Knopf OpenAlex Published psilocybin DepressionAddictionOCD Other More
